Interviews
In this interview we speak to Michael Bachman (University of Michigan MI, USA) about his research on the factors involved in Klebsiella colonization and infection, and whether these could be used to stratify high-risk patients in the future.
Take a look behind the scenes of a recent Future Microbiology editorial, entitled ‘Tick-borne diseases on the rise: an ounce of prevention is worth a pound of cure’, as we ask the author about the increasing prevalence of these diseases and what can be done to prevent them.
In this interview we speak to Vincent Racaniello, Professor of Microbiology & Immunology, about his work on polio, picornaviruses and publicizing science through blogs and podcasts.
Graham Hatfull speaks about heading up the SEA-PHAGES project and the role this has played in understanding phage diversity and evolution, in addition to commenting on a recent case where a phage cocktail was used to treat a case of Mycobacterium abscessus.
In this interview we speak to Leah Blondeau about her research into the pathogens that can be passed from companion animals to humans, recently presented in a poster at the European Congress of Clinical Microbiology and Infection Disease.
In this interview we speak to Chikwe Ihekweazu, current Director of the Nigeria Centre for Disease Control, about monkeypox, public trust, surveillance and the factors that influence preparedness.
Could board games be used as an educational tool to help teach and raise awareness around some of the major challenges in infectious diseases? In this interview we speak to Salam Abbara about the game she has helped develop, which aims to help medical students learn and understand antibiotic prescribing.
In this interview we speak to Daniella Lefteri about her research on modulating arbovirus infection by targeting mosquito saliva, and what avenues this could present for new antiviral treatments.
Take a look behind the scenes of a recent Future Microbiology review, entitled ‘How could ethnicity-associated microbiomes contribute to personalized therapies?’, as we ask the authors about the factors that influence the microbiome composition, how these could be manipulated and the future of this field.
In this interview we talk to Jose Arribas about the challenges facing antiretroviral treatments and the future of long-acting formulations for HIV. What new drugs might we have for this disease in the coming years? Read our interview to find out more.
